
Early studies suggested that the induction of an effective immune response could lead to elimination of residual zzso Over a hundred years ago Coley invented his eponymous named zzso that appeared to induce a strong inflammatory response, leading to zzso zzso zzso attempts to enhance the immune response have essentially been on a vaccine basis, trying to induce a specific response against the zzso Numerous vaccine approaches have claimed to give significant clinical benefit in clinical response but very few of these have survived a zzso zzso A major reason for this is the zzso of many zzso as well as the various forms of zzso against an immune response that they zzso It was thought that chemotherapy and zzso were mutually exclusive for zzso using the vaccine zzso More recently, however, it has become appreciated that vaccine approaches may enhance subsequent responses to zzso and that certain zzso actually enhance responses to zzso It has been suggested that one of the mechanisms of action of chemotherapy is to reduce the cells that suppress zzso These cells primarily defend the zzso from an zzso attack, but more recently it has been suggested that the benefit may zzso other aspects, such as enhancing zzso zzso One reason why zzso approaches may be so useful in cancer is that many zzso evolve out of a chronic inflammatory environment that actively suppresses cell zzso immune responses and enhances zzso zzso An ideal cancer drug would therefore be expected to have these zzso One such drug is zzso which features include marked immune zzso properties as well being able to inhibit regulatory zzso They have also been shown to enhance zzso activity with vaccines in both zzso models and more recently in clinical zzso where the responses to vaccines in patients with myeloma is much higher when they are on zzso than other zzso A number of regularly used chemotherapy regimens have marked activity in modulating the immune zzso These maybe of benefit and the regimens will be zzso which include zzso zzso and the zzso 

